ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 540

Two Years Sacroiliac Radiographic Progression Rate and Influence of Baseline Markers of Inflammation in Recent Onset Spondyloarthritis

Maxime Dougados1, Christophe Demattei2, Rosaline van den Berg3, Viet Vo Hoang4, Fabrice Thévenin5, Monique Reijnierse6, Damien Loeuille7, Antoine Feydy8, Pascal Claudepierre9 and Désirée van der Heijde10, 1INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France, 2Service BESPIM, CHU, Nimes, France, 3Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Department of radiology, Lyon, France, 5Radiology B, Paris Descartes University, Côchin Hospital, APHP, Paris, France, 6Radiology, Leiden University Medical Center, Leiden, Netherlands, 7Rhumatology, CHU Nancy, Vandoeuvre Les Nancy, France, 8Paris Descartes University, Radiology B department, Cochin Hospital, paris, France, 9Rheumatology, Paris-Est University; LIC EA4393; APHP, Henri Mondor Hospital, Creteil, France, 10LUMC, Leiden, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: epidemiologic methods and spondylarthropathy, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: According to the ASAS axial spondyloarthritis (SpA) criteria, patients suffering from inflammatory back pain (IBP) can be recognized as suffering from axial SpA even in the absence of structural damage of the sacroiliac joints (SIJ) but the natural history of these patients is not well known.The objective of this study was to evaluate 1) the rate of SIJ structural progression over a 2 years period and 2) the influence of baseline objective signs of inflammation on this progression rate in patients suffering from recent onset inflammatory back pain suggestive of SpA.

Methods: Patients: IBP < 3 years duration suggestive of axial SpA according to the treating rheumatologist (DESIR cohort) Outcome measures: Pelvic X-rays collected both at baseline and at the 2 year follow up visit and MRI of the SIJ collected at baseline were stored after anonymizing and blinding for the visit. Radiographic structural damage was defined as the fulfillment of the modified New-York (mNY) criteria and inflammation on MRI (“positive MRI”) was defined according to the ASAS criteria. The radiographs and MRIs were read centrally by two pairs of well calibrated central readers blinded for clinical, laboratory and other imaging data. In case of disagreement, images were adjudicated by an experienced radiologist. CRP at baseline was defined as abnormal if >6mg/l.

Results: Of the 708 enrolled patients, 449 had a complete radiological data set (34 + 9 years old, 53 % females, HLA B27 positive: 61%). At baseline, 123 of 449 (27%) fulfilled the mNY criteria. Of the remaining 326 patients, 16 (4.9%) progressed (fulfilling the mNY criteria at the 2 year visit). Among these 326 patients, baseline MRI, CRP and both MRI and CRP were available in 307, 314 and 303 patients respectively. The table summarizes the main findings of this study. MRI positivity, CRP abnormality and either MRI positivity or CRP abnormality was observed in 14/15 (93%) versus 67/292 (23%), 7/15 (46%) versus 61/299 (20%) and 14/15 (93%) versus 111/288 (39%) of the patients with versus without a radiographic progression after the 2 year follow-up visit. A normal MRI and CRP at baseline almost excluded the development of sacroiliitis according to the mNY criteria after two years

Table : SIJ structural progression among the 326 patients not fulfilling SIJ mNY criteria at baseline

SIJ structural progression
Baseline Variable mNY Positive at year 2 mNY Negative at year 2  
MRI positive 14* 67 OR: 47.0[6.1-364.1]
PPV: 0.17
NPV:0.004
negative 1 225
abnormal 7 61
CRP normal 8 238 OR:3.4[1.2-9.8]
PPV:0.10
NPV:0.033
presence 14 111
Inflammation** absence 1 177 OR:23.3[2.9-172.1]
PPV:0.11
NPV:0.006

*values given are the number of patients and OR []: Odds ratio [95% confidence interval]; PPV: positive predictive value; NPV: negative predictive value**baseline inflammation : either MRI positive or abnormal CRP

Conclusion: These data suggest that 1) SIJ structural progression to fulfillment of mNY criteria in this cohort was low after a two years follow-up period 2) the presence of objective signs of inflammation are a predisposing factor of structural progression keeping in mind that the majority of patients with baseline signs of inflammation did not progress.


Disclosure:

M. Dougados,

Pfizer Inc,

2;

C. Demattei,
None;

R. van den Berg,
None;

V. Vo Hoang,
None;

F. Thévenin,
None;

M. Reijnierse,
None;

D. Loeuille,
None;

A. Feydy,
None;

P. Claudepierre,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/two-years-sacroiliac-radiographic-progression-rate-and-influence-of-baseline-markers-of-inflammation-in-recent-onset-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology